Advertisement

Topics

Hovione FarmaCiencia SA Company Profile

22:47 EDT 24th September 2017 | BioPortfolio


News Articles [9 Associated News Articles listed on BioPortfolio]

Hovione launches first clinical trial, more to come

Hovione has launched of its first clinical trial and has already set sights on a second as the CDMO hopes to establish licensing partnership with pharma, says VP.

Hovione FarmaCiencia SA Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 10052017] Prices from USD $250

SummaryHovione FarmaCiencia SA Hovione is a pharmaceutical company that develops and manufactures active pharmaceutical ingredients APIs and drug product intermediates. It offers offpatent API product...

Hovione FarmaCiencia SA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24082017] Prices from USD $250

SummaryHovione FarmaCiencia SA Hovione is a pharmaceutical company that develops and manufactures active pharmaceutical ingredients APIs and drug product intermediates. It offers offpatent API product...

Hovione Announces Start of Phase 1 Clinical Trial of HY02, a Proprietary Minocycline Sterile Ointment to Treat a Subset of Anterior Ocular Inflammation

CORK, Ireland, May 25, 2017 /PRNewswire/ -- Hovione today announced the launch of its first clinical trial. Hovione will soon initiate recruitment for its Phase 1 clinical trial of HY02, a proprie...

Hovione Announces Start Of Phase l Clinical Trial Of HY02, A Proprietary Minocycline Sterile Ointment To Treat A Subset Of Anterior Ocular Inflammation

  Life Sciences Jobs   ...

Hovione Starts Phase 1 Clinical Trial of HY02

HY02 is a proprietary minocycline sterile ointment to treat a subset of anterior ocular inflammation

Clinical trial launched for eye ointment offering topical delivery of antibiotic

Hovione has announced the launch of its Phase I clinical trial of its minocycline sterile ointment, HY02, for the treatment of a subset of ocular surface inflammation.

Global Dry Powder Inhaler Device Market Research 2011 2022 [Report Updated: 12042017] Prices from USD $1520

SummaryThe global Dry Powder Inhaler Device market is estimated to reach 645 Million USD in 2017. The objective of report is to define, segment, and project the market on the basis of type, applicatio...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Hovione FarmaCiencia SA

Hovione SA

Corporate descriptionHovione is an international group dedicated to the synthesis of APIs and serving exclusively the Pharma industry. With FDA inspected plants in Europe and the Far East and sales o...

Hovione

A Hovione foi fundada em 1959 por Ivan Villax, investigador químico, empenhado no desenvolvimento de tetraciclinas e corticoesteroídes anti-inflamatórios. O sucesso da investigação, financiada pe...

More Information about "Hovione FarmaCiencia SA" on BioPortfolio

We have published hundreds of Hovione FarmaCiencia SA news stories on BioPortfolio along with dozens of Hovione FarmaCiencia SA Clinical Trials and PubMed Articles about Hovione FarmaCiencia SA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hovione FarmaCiencia SA Companies in our database. You can also find out about relevant Hovione FarmaCiencia SA Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record